Our animal results also suggest that FAK inhibitors have an inhibitory effect on breast cancer cells with FAK-copy-gain but only a minimal effect on cells with no FAK-copy-gain, which is quite consistent with our in vitro results. The gene discussed is PTK2; the disease is breast cancer.